{"url_path":"/sec/adct/8-k/2026-06-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1771910/0000950103-26-008321-index.html","accession_number":"0000950103-26-008321","cik":"0001771910","ticker":"ADCT","issuer_name":"ADC Therapeutics SA","edgar_url":"https://www.sec.gov/Archives/edgar/data/1771910/0000950103-26-008321-index.html","primary_entity_key":"0001771910","primary_entity_name":"ADC Therapeutics SA"},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\n**Exhibit Number**\n**Description**\n\n[3.1](dp247757_ex0301.htm)\n[Articles of Association of ADC Therapeutics SA](dp247757_ex0301.htm)\n\n104\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nthe registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**ADC Therapeutics SA**\n\nDate: June 2, 2026\n \n\n \n \n\n \nBy:\n/s/ Peter J. Graham\n\n \nName:\nPeter J. Graham\n\n \nTitle:\nChief Legal Officer"}